Description
The FDA’s Center for Biologics Evaluation and Research (CBER) seeks a stand‑alone BactoBox or equivalent bacterial flow cytometer to support assay development for live biotherapeutic products (LBPs) and fecal microbiota transplantation (FMT) products. The instrument must count viable bacterial cells rapidly (under 5 minutes per sample), provide a 2‑log linear range, be portable/benchtop, include necessary software, peripherals, consumables for 200 runs, and carry a one‑year manufacturer warranty with unlimited support. Only small businesses (≤1,000 employees) may submit quotes. The award will be a firm‑fixed‑price contract for one unit, delivered FOB destination to the FDA lab in Silver Spring, MD.
• Required product: BactoBox or equal bacterial flow cytometer (stand‑alone)
• Technical specs: <5 min per sample, 2‑log linear range, viable cell enumeration, portable/benchtop, full software suite, dilution dispenser, flow cells, consumables for 200 runs, 1‑year warranty, unlimited support
• Quantity: 1 unit, FOB destination to FDA CBER lab, Silver Spring, MD
• Contract type: Firm Fixed‑Price, Small‑Business set‑aside (NAICS 334516)
• Submission deadline: 2:00 pm CDT, 1 September 2026 (email to Tim Walbert)
• Evaluation: Lowest‑priced technically acceptable offer; technical acceptability verified via documentation, ACR for Section 508 compliance, and warranty/support terms.
• Mandatory registrations: SAM/UEI active by receipt deadline; compliance with Buy‑American and Section 508 requirements.